Reunion Neuroscience Stock (NASDAQ:REUN)


OwnershipChart

Previous Close

$1.13

52W Range

$0.63 - $21.56

50D Avg

$1.02

200D Avg

$1.12

Market Cap

$13.12M

Avg Vol (3M)

$429.86K

Beta

4.20

Div Yield

-

REUN Company Profile


Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

16

IPO Date

Oct 07, 2020

Website

REUN Performance


Latest Earnings Call Transcripts


Q3 23Feb 14, 23 | 6:26 PM
Q2 23Nov 15, 22 | 5:09 PM
Q1 23Aug 16, 22 | 11:25 AM

Peer Comparison


TickerCompany
SNTISenti Biosciences, Inc.
NUVLNuvalent, Inc.
BLCMBellicum Pharmaceuticals, Inc.
OKYOOKYO Pharma Limited
HILSTharimmune, Inc.
CINGCingulate Inc.